ENLIGHT Annual Meeting and Training 2019, Caen
IMPORTANT: The presentations are available on this webpage. If you wish to utilize them, please contact the speakers.
The European Network for Light Ion Hadron Therapy (ENLIGHT) was established in 2002 following various European particle therapy network initiatives during the 1980s and 1990s. ENLIGHT started its work on major topics related to hadron therapy (HT), such as patient selection, clinical trials, technology, radiobiology, imaging and health economics. It was initiated through CERN and ESTRO and dealt with various disciplines such as (medical) physics and engineering, radiation biology and radiation oncology. A regular annual meeting structure was started in 2002 and continues until today bringing together the various disciplines and projects and institutions in the field of HT at different European places for regular exchange of information on best practices and research and development.
The 17th ENLIGHT annual meeting will be taking place on 1st to 3rd July 2019 in the Centre François Baclesse, 3 avenue Général Harris, F-14000 CAEN - in the Teaching Department (Service d’enseignement) ground floor (“rez-de-jardin”).
We look forward to meeting you in Caen.
CALL FOR ENLIGHT ABSTRACTS: We invite you to submit your abstract for presenting a poster following the guidelines, following link below on this page. The authors of the best three posters will be granted the possibility to give an oral presentation. Deadline: June 24, 12:00 (CET)
Get involved
Become a member of the ENLIGHT network: Register here
ENLIGHT in the framework of CERN & Society - Support the CERN & Society Programme with your donation
Together, we can do even greater things!
ENLIGHT Coordination Office
European Organization for Nuclear Research
Phone: +41 22 767 17 91
Email: enlight@cern.ch
Sponsors:
For more information, please contact Mr Claude Dupont claude.dupont@iba-group.com
-
-
08:30
Coffee and registration
-
1
Welcome talk(s)Speakers: A. Mahé Marc, Jacques BALOSSO (ARCHADE/FranceHADRON), Manjit Dosanjh (CERN)
-
Didactic Session
-
2
Biomarkers and liquid biopsy from an experimental point of view
The goal is to initiate young scientists to the interest of biomarkers, how to retrieve them, how to handled them, what are de scientific questions about them and what kind of scientific hypothesis can be addressed by biomarkers…
Speaker: Siamak Haghdoost (Caen University, FR)
-
2
-
Workshop 1: Practical access to experimental platforms in Europe and Japan
-
3
RADIATE
RADIATE is funded by the EU Research and Innovation programme Horizon 2020 and is committed to providing easy access for researchers from academia and industry to the participating ion beam facilities. About 15.800 hours of transnational access in total is offered free of charge to users who pass the RADIATE proposal procedure.
Speaker: Henning Lebius (Cimap/GANIL, FR) -
4
WP6 EPTN Review of beam access in EuropeSpeaker: Manjit Dosanjh (CERN, ENLIGHT)
-
5
MediNet
MediNet, within ENSAR2, is a network that focuses on the development of tools to be used for medical applications and specifically on radiation therapy. The main emphasis is put on applications for ion-beam therapy with two distinct pillars: Research on detector instrumentation for radiation therapy and development of nuclear tools for the radiation quality characterization in ion-beam therapy.
Speaker: Giulio Magrin (MedAustron, AU)
-
3
-
11:30
Coffee break
-
Workshop 1: Practical access to experimental platforms in Europe and Japan
-
6
Summary of the GSI: FAIR access and beam offerSpeaker: Martina C. Fuss (GSI, GE)
- 7
-
8
General discussion as a round table, demands, how to apply, advises, examples, cost, collaboration
-
6
-
13:30
Lunch
-
14:30
Coffee break
-
Workshop 2: Animal models for PT experimentation
(the goal is to give practical information for developing the use of an animal model for tumour and normal tissue experiments)
Conveners: Cyrille Orset , Kevin Prise, Dr Myriam* Bernaudin (Normandie Univ, UNICAEN, CEA, CNRS, ISTCT/CERVOxy group, GIP Cyceron, Caen, France)-
9
Reminder of the global European regulation on the use of animal modelsSpeaker: Cyrille Orset (Cycéron)
-
10
Examples of platform working with animal models: INFN CataneSpeaker: Francesco Paolo Cammarrata (IBFM/CNR, Italy)
-
11
Examples of platform working with animal models: The OncoModel platform in CaenSpeaker: Samuel Valable (CYCERON, Caen)
-
12
Examples of platform working with animal models: The ICPO RadExp platform in OrsaySpeakers: Annalisa Patriarca (Institut-Curie Recherche, Orsay), Frédéric Pouzoulet (Institut-Curie Recherche, Orsay)
-
13
Examples of platform working with animal models: Organ-on-chip as human analog model for in-vivo particle irradiation studiesSpeaker: Frederic Zenhausen (University of Arizona Cancer Center, USA)
-
14
Remnant of Workshop 1: INSPIRE protons beam access
Led by the University of Manchester, INSPIRE is a Horizon 2020 funded European Research Project that aims to provide a world-leading integrating activity for European research in Proton Beam Therapy (PBT). Inspire’s Transnational Access infrastructure is dedicated to providing free access to research rooms in clinical proton beam therapy centres across Europe.
Speaker: Pawel Olko (KPTC, Poland) -
15
Remnant of Workshop 1: ERINS project (after ENSAR2)
ERINS is a project supposed to continue the ENSAR2 project which is a European Network Research Infrastructure supported for applied nuclear physics in Europe.
Speaker: Marek Lewitowicz (GANIL, FR)
-
9
-
Summary, and global discussion or conclusion
-
08:30
-
-
08:30
Coffee and Registration
-
16
Welcome Talk
-
Session I: Quality assurance, advanced instrumentation and organ motionConveners: AM Frelin, Vincenzo Patera (University of Rome Sapienza)
- 17
-
18
Patient QA by on line imagingSpeaker: Dr Denis Dauvergne (LPSC, CNRS/IN2P3- Grenoble University)
-
19
Organ motion control, clinical practiceSpeaker: Alessandro Vai (CNAO, Italy)
-
20
Organ motion control, advanced conceptsSpeaker: Ye Zhang (PSI, Switzerland)
-
21
Organ motion modelizationSpeaker: Hamid Ladjal (LIRIS, Lyon)
- 22
-
11:15
Coffee break and Poster
-
Session II: Radiobiology (I) and Progress in Dose Calculation in PTConveners: C Rodriguez-Lafrasse (Lyon), Thomas Schmid (Klinikum rechts der Isar, TU München)
-
23
Unusual dose delivery questioning radiobiology (1): Flash effectSpeaker: Jean Bourhis (CHUV, Lausanne)
-
24
Radiobiology and progress in dose calculation in PT: the FRoG platformSpeaker: Andrea Mairani (Fondazione CNAO)
-
25
The NanOx modelSpeaker: Michaël BEUVE (IPNL , Université Lyon 1)
- 26
-
27
Unusual dose delivery questioning radiobiology (2): proton minibeam therapy by focused beamsSpeaker: Gerd Datzmann (Munchen)
-
23
-
13:10
Lunch on site plus posters visit and poster jury working
-
Session III: Radiobiology (II)
- 28
-
29
Nanoparticles entering practiceSpeaker: Prof. Jacques BALOSSO (ARCHADE/FranceHADRON)
-
30
Specific aspects of tumor cells' response to carbon ionsSpeaker: C Rodriguez-Lafrasse (Lyon)
-
31
Is Hypoxia sensitive to particle therapySpeaker: Walter Tinganelli (GSI)
- 32
-
33
General discussion on radiology sessions II and III
-
16:15
Coffee break and poster visit
-
Session IV: Introduction Talk about ARCHADE - CYCLHADConvener: Jacques BALOSSO (ARCHADE/FranceHADRON)
-
17:00
Shuttle transfer to CYCLHAD - three groups
-
34
Visit of CYCLHAD center and poster presentation of ARCHADE project in Caen
-
35
Shuttle transfer from CYCLHAD to Caen town hall
-
19:30
Social Event and Dinner
At the Abbaye aux Hommes, Townhall of Caen
For 19:30, visit, welcome address, a proclamation of awards, other…
-
08:30
-
-
08:30
Coffee and Registration
-
Session V (first part): Results or progresses in ongoing clinical trials
(the goal is to share information on the progress of ongoing clinical trials, difficulties, failures, prospects of results, a project of multicentric comparative studies)
Conveners: Juliette Thariat (Unicaen, CFB, Archade), Robert Miller (Michigan State University)- 36
- 37
-
38
the collaborative pancreatic trials in Europe and ChinaSpeaker: Piero Fossati (MedAustron)
-
10:30
Coffee break and poster visit
-
Session V (second part): Results or progresses in ongoing clinical trials
-
39
Advance of the PHRC-ETOILE (Fr-It)Speaker: Jacques BALOSSO (ARCHADE/FranceHADRON)
-
40
TBC
-
41
The need for randomized clinical trials in PTSpeaker: Enrico Clementel (University of Ghent)
-
42
Project of an international surveySpeaker: Y. Santigny 6
-
39
-
12:30
Lunch on Site
-
Session VI: Poster Session: Poster awards winners presentationConveners: Jacques BALOSSO (ARCHADE/FranceHADRON), Manjit Dosanjh (CERN)
-
43
Award for Sébastien Curtoni
-
44
Award for Olivier Guipaud
-
45
Award for Stewart Mein
-
43
-
Session VII: Facilities progress, new projects and new technology designConveners: Jean-Marc Fontbonne (CNRS), Simona Giordanengo (Istituto Nazionale di Fisica Nucleare)
-
46
Centres advancement (MedAustron, Aarhus, Manchester, Maastricht, Groningen)Speaker: Pawel Olko
-
47
An overview of different new techniques/options/methods that are being studied/proposed at the momentSpeaker: Jacobus Maarten Schippers
- 48
-
49
Particle therapy status in South KoreaSpeaker: Woo-Yoon Park (Chungbuk National University)
-
46
-
16:00
Coffee break and poster visit
-
Session VIII: Presentations from IndustryConvener: T Teissonnier
-
50
Mevion: Advances in integrated compact single-room proton therapy systemsSpeaker: Sara La Civita (enlight@cern.ch)
-
51
IBA: Defining the future of Proton Therapy with Arc and FlashSpeaker: Claude Dupont
-
50
-
52
Announcement of ENLIGHT 2020 and closure, farewellSpeaker: Olav Dahl (Norway)
-
08:30